Literature DB >> 17920364

Comparison between dobutamine echocardiography and single-photon emission computed tomography for interpretive reproducibility.

Adele Ferro1, Teresa Pellegrino, Letizia Spinelli, Wanda Acampa, Mario Petretta, Alberto Cuocolo.   

Abstract

Interpretive variability of dobutamine stress echocardiography (DSE) and stress single-photon emission computed tomography (SPECT) has been previously investigated. However, no study has directly compared the variability of these techniques in the same patient population. We directly compared the interpretive reproducibility of DSE and stress SPECT in patients undergoing both types of pharmacologic stress imaging. Before discharge, simultaneous DSE and SPECT was performed in 56 patients early after a first acute myocardial infarction. Intra- and interobserver concordances were evaluated by exact agreement and kappa statistic. Intraclass coefficient of correlation was used to assess intra- and interobserver reproducibilities of segmental score analysis. Intraobserver agreement percentages in the identification of patients with ischemia were 98% for SPECT and 91% for DSE (p = NS) and kappa values were excellent (>0.80) for both techniques. Interobserver agreement was higher (p <0.01) for SPECT (96%) than for DSE (79%). Similarly, kappa value was excellent for SPECT (0.92) and only moderate for DSE (0.56). Finally, the intraclass coefficients of correlation for intra- and interobserver reproducibilities were higher for SPECT (0.98 and 0.97, respectively) than for DSE (0.80 and 0.71, respectively; p <0.001 for both). In conclusion, after uncomplicated acute myocardial infarction, stress SPECT imaging has a better interpretive reproducibility than DSE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920364     DOI: 10.1016/j.amjcard.2007.05.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Fractional flow reserve and myocardial viability as assessed by SPECT perfusion scintigraphy in patients with prior myocardial infarction.

Authors:  Branko Beleslin; Milan Dobric; Dragana Sobic-Saranovic; Vojislav Giga; Jelena Stepanovic; Ana Djordjevic-Dikic; Milan Nedeljkovic; Sinisa Stojkovic; Vladan Vukcevic; Goran Stankovic; Dejan Orlic; Zorica Petrasinovic; Smiljana Pavlovic; Vladimir Obradovic; Miodrag Ostojic
Journal:  J Nucl Cardiol       Date:  2010-06-04       Impact factor: 5.952

2.  Reproducibility and accuracy of non-invasive measurement of infarct size in mice with high-resolution PET/CT.

Authors:  Adelaide Greco; Maria Piera Petretta; Michele Larobina; Sara Gargiulo; Mariarosaria Panico; Stephan G Nekolla; Giovanni Esposito; Mario Petretta; Arturo Brunetti; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2012-03-07       Impact factor: 5.952

3.  Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial.

Authors:  Fiore Manganelli; Marco Spadafora; Paola Varrella; Giuseppina Peluso; Rosario Sauro; Emilio Di Lorenzo; Giuseppe Rosato; Stefania Daniele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02       Impact factor: 9.236

4.  Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function.

Authors:  Francesco Giallauria; Wanda Acampa; Francesca Ricci; Alessandra Vitelli; Giorgio Torella; Rosa Lucci; Giuseppina Del Prete; Emilia Zampella; Roberta Assante; Giuseppe Rengo; Dario Leosco; Alberto Cuocolo; Carlo Vigorito
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-06       Impact factor: 9.236

5.  Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease.

Authors:  Bradley A Bart; Ye-Ying Cen; Robert C Hendel; Ramond Lee; Thomas H Marwick; Emil D Missov; Fouad A Bachour; Charles A Herzog
Journal:  J Nucl Cardiol       Date:  2009-03-24       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.